← FDA DRUG APPROVALS

FDA ANDA · ANDA077756

LEVALBUTEROL HYDROCHLORIDE

Sponsor: IMPAX LABS INC

APPLICATION
ANDA077756
TYPE
ANDA
ORIGINAL APPROVAL
2008-04-09
LATEST ACTION
2017-12-27
ROUTE
INHALATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

LEVALBUTEROL HYDROCHLORIDEPrescription
LEVALBUTEROL HYDROCHLORIDE EQ 0.0103% BASE · SOLUTION · INHALATION
LEVALBUTEROL HYDROCHLORIDEPrescription
LEVALBUTEROL HYDROCHLORIDE EQ 0.021% BASE · SOLUTION · INHALATION
LEVALBUTEROL HYDROCHLORIDEPrescription
LEVALBUTEROL HYDROCHLORIDE EQ 0.042% BASE · SOLUTION · INHALATION

Approval history

2017-12-27Labeling · Supplement 3 · standardAP
2008-04-09OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →